Serum Pepsinogen I, Pepsinogen II, and Gastrin 17 in Relatives of Gastric Cancer Patients: Comparative Study With Type and Severity of Gastritis  Arghavan.

Slides:



Advertisements
Similar presentations
Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America  David Y. Graham, Zhannat Z. Nurgalieva, Hala M.T.
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Alan N. Desmond, Sebastian McWilliams, Michael M
Pichamol Jirapinyo, Christopher C. Thompson 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Katsunori Matsueda, Tatsuya Toyokawa 
Morgagni's Hernia Clinical Gastroenterology and Hepatology
A Shocking Cystory Clinical Gastroenterology and Hepatology
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Noninvasive Versus Histologic Detection of Gastric Atrophy in a Hispanic Population in North America  David Y. Graham, Zhannat Z. Nurgalieva, Hala M.T.
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Diffuse Gastric Wall Thickening: Appearances Can Be Deceptive
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Helicobacter pylori Eradication and Metachronous Gastric Cancer
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma  Emmanouil Sinakos,
Jennifer J. Williams, Gilaad G. Kaplan, Sapna Makhija, Stefan J
Judy A. Trieu, Mohammad Bilal, Ali Hashmi 
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Endocuff to Improve Adenoma Detection: Supported by Low-Quality Evidence or Not Supported by High-Quality Evidence?  Yao Zhang, MD, Sheng-Bing Zhao, MD 
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Endoscopy 20 Years Into the Future
Jessica L. Mellinger, Michael L. Volk 
Eighty-Year-Old Patient With History of a Twelve Millimeter Adenomatous Polyp Resected at Age of Seventy-Five Years  David Lieberman  Clinical Gastroenterology.
May Min, Jason Ferreira, Charles Wang 
Endoscopic Therapy for Barrett's Esophagus
Amie L. Harvey, Tommy Yen, Anand Kunda 
When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?  Folasade P. May, Samir Gupta  Clinical Gastroenterology.
Novel Endoscopic Therapeutics for Early Gastric Cancer
Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis  John Gubatan, Shuji Mitsuhashi, Talia Zenlea,
Miho Sakumura, Kazuto Tajiri, Toshiro Sugiyama 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer  Shari S. Rogal, Paul F. Pinsky, Robert E.
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Issue Highlights Clinical Gastroenterology and Hepatology
Kaposi’s Sarcoma Involving the Gastrointestinal Tract
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patient-Reported Outcomes of Cirrhosis
Colorectal Cancer Screening: How to Stop a Moving Target
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome
Issue Highlights Clinical Gastroenterology and Hepatology
Heiko Pohl, Douglas J. Robertson 
Alan Bonder, MD, Nezam H. Afdhal, MD 
Issue Highlights Clinical Gastroenterology and Hepatology
John Scott Maul, Randall W. Burt, Lisa A. Cannon–Albright 
Thrombocytopenia With Abnormal Liver Function Tests
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Familial Colorectal Cancer, Beyond Lynch Syndrome
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Hairball in the Stomach: A Case of Gastric Trichobezoar
Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Gastric Metastases From Anaplastic Pancreatic Cancer
Issue Highlights Clinical Gastroenterology and Hepatology
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
An Unusual Case of Gastritis and Duodenitis After Yttrium 90–Microsphere Selective Internal Radiation  Jessica Baumann, Mark Lin, Charmi Patel  Clinical.
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Serum Pepsinogen I, Pepsinogen II, and Gastrin 17 in Relatives of Gastric Cancer Patients: Comparative Study With Type and Severity of Gastritis  Arghavan Haj–sheykholeslami, Naser Rakhshani, Aliakbar Amirzargar, Reza Rafiee, S. Mehdi Shahidi, Behrouz Nikbin, Farideh Khosravi, Sadegh Massarrat  Clinical Gastroenterology and Hepatology  Volume 6, Issue 2, Pages 174-179 (February 2008) DOI: 10.1016/j.cgh.2007.11.016 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 ROC curves generated with PGI (gray line), PGII (black line), PG I:II (gray dashed line), and gastrin 17 (black dashed line) for detecting any kind of gastritis among first-degree relatives of gastric cancer patients. The area under the curve is 0.67 for PGI, 0.85 for PGII, 0.27 for PG I:II ratio, and 0.67 for gastrin 17. Clinical Gastroenterology and Hepatology 2008 6, 174-179DOI: (10.1016/j.cgh.2007.11.016) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 ROC curves generated with PGI (gray line), PGII (black line), PG I:II (gray dashed line), and gastrin 17 (black dashed line) for detecting corpus-predominant gastritis among first-degree relatives of gastric cancer patients. The area under the curve is 0.47 for PGI, 0.65 for PGII, 0.28 for ratio, and 0.66 for gastrin 17. Clinical Gastroenterology and Hepatology 2008 6, 174-179DOI: (10.1016/j.cgh.2007.11.016) Copyright © 2008 AGA Institute Terms and Conditions